A 'Goldilocks' dose for Biogen's Alzheimer's drug?
July 17, 2015 at 13:08 PM EDT
Biogen is looking to settle on one key thing: the perfect dose for its experimental Alzheimer's drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.